Location History:
- Palo Alto, CA (US) (2020)
- Somerville, MA (US) (2021 - 2023)
Company Filing History:
2 out of 2 
2 out of 2,963 
1 out of 1 Years Active: 2020-2025
Title: John Hanney McGee: Innovator in Peptide Technologies
Introduction
John Hanney McGee is a notable inventor based in Somerville, MA, with a focus on peptide technologies. He holds five patents that contribute significantly to the field of biochemistry and molecular biology. His work has implications for various medical applications, particularly in the modulation of beta-catenin functions.
Latest Patents
Among his latest patents is a disclosure on collections of peptides, peptide agents, and methods of use thereof. This patent provides powerful technologies for the development, production, characterization, and use of stapled peptide compositions. It outlines strategies for defining amino acid sequences that are particularly amenable to stapling, along with technologies, reagents, and systems for developing and using these stapled peptides. Another significant patent focuses on agents modulating beta-catenin functions and methods thereof. This patent presents technologies for modulating the functions of beta-catenin, including stapled peptides that interact with beta-catenin at an Axin-binding site. The patent also discusses compounds and methods for preventing and treating conditions associated with beta-catenin.
Career Highlights
John Hanney McGee has had a distinguished career, working with prominent organizations such as Fog Pharmaceuticals, Inc. and Harvard College. His contributions to these institutions have advanced the understanding and application of peptide technologies in therapeutic contexts.
Collaborations
Throughout his career, McGee has collaborated with notable colleagues, including Gregory Lawrence Verdine and Gerard Hilinski. These collaborations have further enriched his research and development efforts in the field of peptide science.
Conclusion
John Hanney McGee's innovative work in peptide technologies and his contributions to the scientific community underscore his role as a leading inventor in this specialized field. His patents not only advance scientific knowledge but also hold promise for future medical applications.